Clinical strategy of repeat biopsy in patients with atypical small acinar proliferation (ASAP)
Abstract Atypical small acinar proliferation (ASAP) occurs in approximately 5% of prostate biopsies. Approximately 30–40% of patients with ASAP have biopsy detectable prostate cancer (PCa) within 5 years. Current guidelines recommend a repeat biopsy within 3–6 months after the initial diagnosis. The...
Main Authors: | Hwanik Kim, Jung Kwon Kim, Gheeyoung Choe, Sung Kyu Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-02172-8 |
Similar Items
-
Biopsy follow-up in patients with isolated atypical small acinar proliferation (ASAP) in prostate biopsy
by: Luca Leone, et al.
Published: (2014-12-01) -
Histomorphological Features of Atypical Small Acinar Proliferations (ASAP) That Favor Malignancy
by: Ayşe Gökçen Sade, et al.
Published: (2021-01-01) -
The impact of repeated prostate biopsies on sexual function and urinary symptoms in patients with diagnosis of Atypical Small Acinar Proliferation (ASAP): Can ecoDoppler reduce side effects?
by: Luigi Quaresima, et al.
Published: (2014-12-01) -
Prostate biopsies containing prostate intraepithelial neoplasia and atypical small acinar proliferation: what to do?
by: Fernando Korkes, et al.
Published: (2009-12-01) -
How many cores should be taken in a repeat biopsy on patients in whom atypical small acinar proliferation has been identified in an initial transrectal prostate biopsy?
by: Erdogan Aglamis, et al.
Published: (2014-10-01)